注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Veru Inc是一家生物製藥公司。該公司專注於開髮用於治療急性呼吸窘迫綜合徵(ARDS)和其他病毒相關ARDS高危住院COVID-19患者以及治療乳腺癌和前列腺癌的藥物。該公司在其性健康計劃中提供兩種FDA批准的產品,包括用於治療良性前列腺增生的ENTADFI(他達拉非 5mg 和非那雄胺 5mg 膠囊)和FC2女用避孕套(內部避孕套)(FC2),用於防止意外懷孕的雙重保護以及性傳播感染的傳播。其乳腺癌藥物管線有兩種藥物的四個臨床開發項目,例如口服選擇性雄激素受體靶向激動劑enobosarm和口服細胞骨架破壞劑sabizabulin。其前列腺癌藥物管線包括sabizabulin、VERU-100和zuclomiphene citrate。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Mitchell S. Steiner | 61 | 2016 | Chairman, President & CEO |
Harry Fisch | 63 | 2016 | Vice Chairman & Chief Corporate Officer |
Mario Eisenberger | 74 | 2016 | Independent Director |
Xiaoqin Lu | 49 | 2021 | Independent Director |
Michael L. Rankowitz | 66 | 2018 | Independent Director |
Andrew Sproule Love | 80 | 2013 | Board Observer |
Grace S. Hyun | 52 | 2020 | Independent Director |
Erik Swenson | - | 2023 | Member of the Scientific Advisory Board |
David D. Ho | 71 | 2023 | Chairman of Scientific Advisory Board |
Adrian Sandra Dobs | - | 2024 | Member of Scientific Advisory Board |
Robert T. Schooley | - | 2023 | Member of the Scientific Advisory Board |
William J. Evans | - | 2024 | Member of Scientific Advisory Board |
Shalender Bhasin | - | 2024 | Member of Scientific Advisory Board |
Louis J. Aronne | 68 | 2024 | Chief Medical Advisor & Member of the Scientific Advisory |
Caroline M. Apovian | - | 2024 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核